[Anticholinesterase action of the organophosphorus compound LG-63 in vivo].
D000818:Animals; D001921:Brain / Q000201:enzymology; D002800:Cholinesterase Inhibitors; D002802:Cholinesterases / Q000097:blood / Q000378:metabolism*; D007421:Intestine, Small / Q000201:enzymology; D007668:Kidney / Q000201:enzymology; D008099:Liver / Q000201:enzymology; D008168:Lung / Q000201:enzymology; D008297:Male; D009132:Muscles / Q000201:enzymology; D009206:Myocardium / Q000201:enzymology; D009943:Organophosphorus Compounds / Q000494:pharmacology; D010756:Phosphoric Acids / Q000494:pharmacology*; D051381:Rats; D013270:Stomach / Q000201:enzymology
D002800:Cholinesterase Inhibitors; D009943:Organophosphorus Compounds; D010756:Phosphoric Acids; D002802:Cholinesterases
Antikholinésteraznoe deĭstvie fosfororganicheskogo ingibitora LG-63 in vivo.